Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASKP1240 in moderate to severe plaque psoriasis
NCT01585233Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Apr 2012
- Primary completion
- Jun 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of bleselumab in plaque psoriasis, sponsored by Astellas Pharma. Started Apr 2012; status: completed.
02
Drugs
bleselumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01585233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585233.